Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy.

Drews O, Tsukamoto O, Liem D, Streicher J, Wang Y, Ping P.

Circ Res. 2010 Oct 29;107(9):1094-101. doi: 10.1161/CIRCRESAHA.110.222364. Epub 2010 Sep 2.

2.

COP9 signalosome subunit 8 is required for postnatal hepatocyte survival and effective proliferation.

Lei D, Li F, Su H, Tian Z, Ye B, Wei N, Wang X.

Cell Death Differ. 2011 Feb;18(2):259-70. doi: 10.1038/cdd.2010.98. Epub 2010 Aug 6.

3.

Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts.

Tang M, Li J, Huang W, Su H, Liang Q, Tian Z, Horak KM, Molkentin JD, Wang X.

Cardiovasc Res. 2010 Dec 1;88(3):424-33. doi: 10.1093/cvr/cvq217. Epub 2010 Jul 2.

4.

Myocardial ischemic preconditioning preserves postischemic function of the 26S proteasome through diminished oxidative damage to 19S regulatory particle subunits.

Divald A, Kivity S, Wang P, Hochhauser E, Roberts B, Teichberg S, Gomes AV, Powell SR.

Circ Res. 2010 Jun 25;106(12):1829-38. doi: 10.1161/CIRCRESAHA.110.219485. Epub 2010 Apr 29.

5.

Structural insights into the COP9 signalosome and its common architecture with the 26S proteasome lid and eIF3.

Enchev RI, Schreiber A, Beuron F, Morris EP.

Structure. 2010 Mar 14;18(4):518-27. doi: 10.1016/j.str.2010.02.008.

6.

Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.

Willis MS, Townley-Tilson WH, Kang EY, Homeister JW, Patterson C.

Circ Res. 2010 Feb 19;106(3):463-78. doi: 10.1161/CIRCRESAHA.109.208801. Review.

7.

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies.

Predmore JM, Wang P, Davis F, Bartolone S, Westfall MV, Dyke DB, Pagani F, Powell SR, Day SM.

Circulation. 2010 Mar 2;121(8):997-1004. doi: 10.1161/CIRCULATIONAHA.109.904557. Epub 2010 Feb 16.

8.

Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.

Ranek MJ, Wang X.

Curr Hypertens Rep. 2009 Dec;11(6):389-95. Review.

9.

Markers of autophagy are downregulated in failing human heart after mechanical unloading.

Kassiotis C, Ballal K, Wellnitz K, Vela D, Gong M, Salazar R, Frazier OH, Taegtmeyer H.

Circulation. 2009 Sep 15;120(11 Suppl):S191-7. doi: 10.1161/CIRCULATIONAHA.108.842252.

10.

The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.

Su H, Wang X.

Cardiovasc Res. 2010 Jan 15;85(2):253-62. doi: 10.1093/cvr/cvp287. Epub 2009 Aug 20. Review.

11.

Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase.

Jogo M, Shiraishi S, Tamura TA.

FEBS Lett. 2009 Sep 3;583(17):2715-9. doi: 10.1016/j.febslet.2009.07.033. Epub 2009 Jul 22.

12.

The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Carrier L, Schlossarek S, Willis MS, Eschenhagen T.

Cardiovasc Res. 2010 Jan 15;85(2):330-8. doi: 10.1093/cvr/cvp247. Epub 2009 Jul 17. Review.

13.

Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.

Soucy TA, Smith PG, Rolfe M.

Clin Cancer Res. 2009 Jun 15;15(12):3912-6. doi: 10.1158/1078-0432.CCR-09-0343. Epub 2009 Jun 9.

14.

PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts.

Asai M, Tsukamoto O, Minamino T, Asanuma H, Fujita M, Asano Y, Takahama H, Sasaki H, Higo S, Asakura M, Takashima S, Hori M, Kitakaze M.

J Mol Cell Cardiol. 2009 Apr;46(4):452-62. doi: 10.1016/j.yjmcc.2008.11.001. Epub 2008 Nov 13.

PMID:
19059265
15.

Alpha B-crystallin suppresses pressure overload cardiac hypertrophy.

Kumarapeli AR, Su H, Huang W, Tang M, Zheng H, Horak KM, Li M, Wang X.

Circ Res. 2008 Dec 5;103(12):1473-82. doi: 10.1161/CIRCRESAHA.108.180117. Epub 2008 Oct 30.

16.

Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues.

Gomes AV, Young GW, Wang Y, Zong C, Eghbali M, Drews O, Lu H, Stefani E, Ping P.

Mol Cell Proteomics. 2009 Feb;8(2):302-15. doi: 10.1074/mcp.M800058-MCP200. Epub 2008 Oct 17.

17.

The COP9 signalosome: more than a protease.

Wei N, Serino G, Deng XW.

Trends Biochem Sci. 2008 Dec;33(12):592-600. doi: 10.1016/j.tibs.2008.09.004. Epub 2008 Oct 14. Review.

PMID:
18926707
18.

The COP9 signalosome negatively regulates proteasome proteolytic function and is essential to transcription.

Su H, Huang W, Wang X.

Int J Biochem Cell Biol. 2009 Mar;41(3):615-24. doi: 10.1016/j.biocel.2008.07.008. Epub 2008 Jul 25.

19.

The ubiquitin-proteasome system in cardiac dysfunction.

Mearini G, Schlossarek S, Willis MS, Carrier L.

Biochim Biophys Acta. 2008 Dec;1782(12):749-63. doi: 10.1016/j.bbadis.2008.06.009. Epub 2008 Jun 25. Review.

20.

Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib.

Hacihanefioglu A, Tarkun P, Gonullu E.

Int J Hematol. 2008 Sep;88(2):219-22. doi: 10.1007/s12185-008-0139-7. Epub 2008 Jul 17.

PMID:
18633693

Supplemental Content

Support Center